Azathioprine Completed Phase 3 Trials for Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00355862Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma